Holborn Wells India sets up pharma, med-devices regulatory affairs consulting division
The new division will assist local start-ups and consult foreign companies looking to invest in India in the pharma and medical device sector
Holborn Wells India, an IVD manufacturing company, has launched a Pharmaceutical & Medical Devices Regulatory consulting division to assist local start-ups and consult foreign companies looking to invest in India in the pharma and medical device sector. Over the last few months, Holborn Wells India had multiple queries from various Indian start-ups as well as from Europe & North America related to the regulatory landscape & setting up a manufacturing base in India.
The company is not only able to assist with documentation as per CDSCO guidelines, but with the extensive technical and regulatory experience as a medical device manufacturer, The company can deliver end-to-end services including technical, legal and contract manufacturing services through the channel partners. The intent is to assist the nation in attracting Foreign Direct Investments and act as a catalyst to support ‘Start-up India’ initiative set up by Prime Minister Narendra Modi.
According to Lawrence Perry, Head of International Sales for Holborn Wells India, the Indian market and “Make in India” policy has created a huge platform for various international companies looking to set up bases in India. With liberalised guidelines and regulations, reduction in unnecessary compliance burden, cost reduction and ease of doing business in India, Holborn Wells India expects to see tremendous interest in India because of the Make in India initiative.
